WO2001021582A1 - Biphenylderivate als nhe-3-inhibitoren - Google Patents
Biphenylderivate als nhe-3-inhibitoren Download PDFInfo
- Publication number
- WO2001021582A1 WO2001021582A1 PCT/EP2000/008616 EP0008616W WO0121582A1 WO 2001021582 A1 WO2001021582 A1 WO 2001021582A1 EP 0008616 W EP0008616 W EP 0008616W WO 0121582 A1 WO0121582 A1 WO 0121582A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- formula
- nhe
- solvates
- acid
- Prior art date
Links
- BPNWOLGYJJGREY-UHFFFAOYSA-N NC(c1cccc(COc2cccc(-c3cccc(C(N)=N)c3)c2)c1)=N Chemical compound NC(c1cccc(COc2cccc(-c3cccc(C(N)=N)c3)c2)c1)=N BPNWOLGYJJGREY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0202891A HUP0202891A3 (en) | 1999-09-22 | 2000-09-04 | Biphenyl derivatives used as nhe-3 inhibitors and pharmaceutical compositions containing them |
JP2001524962A JP2004500338A (ja) | 1999-09-22 | 2000-09-04 | Nhe−3阻害剤として用いられるビフェニル誘導体 |
SK334-2002A SK3342002A3 (en) | 1999-09-22 | 2000-09-04 | Biphenyl derivatives used as nhe-3 inhibitors |
CA002387529A CA2387529A1 (en) | 1999-09-22 | 2000-09-04 | Biphenyl derivatives as nhe-3 inhibitors |
EP00965915A EP1214291A1 (de) | 1999-09-22 | 2000-09-04 | Biphenylderivate als nhe-3-inhibitoren |
MXPA02003087A MXPA02003087A (es) | 1999-09-22 | 2000-09-04 | Derivados de bifenilo como inhibidores del nhe-3. |
KR1020027003735A KR20020033818A (ko) | 1999-09-22 | 2000-09-04 | Nhe-3 저해제로서 사용되는 비페닐 유도체 |
BR0014199-2A BR0014199A (pt) | 1999-09-22 | 2000-09-04 | Derivados de bifenila como inibidores de nhe-3 |
AU76497/00A AU7649700A (en) | 1999-09-22 | 2000-09-04 | Biphenyl derivatives used as nhe-3 inhibitors |
NO20021407A NO20021407D0 (no) | 1999-09-22 | 2002-03-21 | Bifenylderivater anvendt som NHE-3-inhibitorer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19945302A DE19945302A1 (de) | 1999-09-22 | 1999-09-22 | Biphenylderivate als NHE-3-Inhibitoren |
DE19945302.0 | 1999-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001021582A1 true WO2001021582A1 (de) | 2001-03-29 |
Family
ID=7922831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/008616 WO2001021582A1 (de) | 1999-09-22 | 2000-09-04 | Biphenylderivate als nhe-3-inhibitoren |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1214291A1 (de) |
JP (1) | JP2004500338A (de) |
KR (1) | KR20020033818A (de) |
CN (1) | CN1555356A (de) |
AU (1) | AU7649700A (de) |
BR (1) | BR0014199A (de) |
CA (1) | CA2387529A1 (de) |
CZ (1) | CZ2002815A3 (de) |
DE (1) | DE19945302A1 (de) |
HU (1) | HUP0202891A3 (de) |
MX (1) | MXPA02003087A (de) |
NO (1) | NO20021407D0 (de) |
PL (1) | PL355097A1 (de) |
SK (1) | SK3342002A3 (de) |
WO (1) | WO2001021582A1 (de) |
ZA (1) | ZA200203095B (de) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005516947A (ja) * | 2001-12-21 | 2005-06-09 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 置換されたイミダゾリジン、その製造方法、その医薬又は診断薬としての使用、及び、置換されたイミダゾリジンを含有する医薬 |
US7049333B2 (en) | 2002-06-04 | 2006-05-23 | Sanofi-Aventis Deutschland Gmbh | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
US7179830B2 (en) | 2003-09-08 | 2007-02-20 | Sanofi-Aventis Deutschland Gmbh | Substituted thienoimidazoles useful for disease treatment and prevention |
US7442717B2 (en) | 2003-02-04 | 2008-10-28 | Sanofi-Aventis Deutschland Gmbh | Substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid |
WO2009006066A2 (en) | 2007-06-28 | 2009-01-08 | Sanofi-Aventis U.S. Llc | Process for the preparation of benzimidazol thienylamine compounds and intermediates thereof |
WO2010025856A1 (en) | 2008-09-02 | 2010-03-11 | Sanofi-Aventis | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
US7868003B2 (en) | 2005-01-12 | 2011-01-11 | Sanofi-Aventis | Substituted 4-phenyltetrahydroisoquinolines, pharmaceutical compositions comprising them and therapeutic methods for their use |
US8067614B2 (en) | 2003-02-04 | 2011-11-29 | Sanofi-Aventis Deutschland Gmbh | N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them |
CN103012200A (zh) * | 2011-09-20 | 2013-04-03 | 北京大学 | 具有β-分泌酶抑制功能的化合物及其制备方法与应用 |
WO2014029983A1 (en) | 2012-08-21 | 2014-02-27 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US8716470B2 (en) | 2011-03-15 | 2014-05-06 | Astellas Pharma Inc. | Guanidine compound |
KR20170034897A (ko) | 2014-07-25 | 2017-03-29 | 다이쇼 세이야꾸 가부시끼가이샤 | 헤테로아릴로 치환된 페닐테트라히드로이소퀴놀린 화합물 |
WO2018129552A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
WO2018129557A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Inhibitors of nhe-mediated antiport |
EP3351248A1 (de) | 2008-12-31 | 2018-07-25 | Ardelyx, Inc. | Verbindungen und verfahren zur inhibierung des nhe-vermittelten antiports bei der behandlung von mit flüssigkeitsretention und salzüberlastung assoziierten erkrankungen und erkrankungen des magen-darm-trakts |
WO2019060051A1 (en) | 2017-08-04 | 2019-03-28 | Ardelyx, Inc. | GLYCYRRHETINIC ACID DERIVATIVES FOR THE TREATMENT OF HYPERKALIEMIA |
US10272079B2 (en) | 2013-04-12 | 2019-04-30 | Ardelyx, Inc. | NHE3-binding compounds and methods for inhibiting phosphate transport |
US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
WO2020163642A1 (en) | 2019-02-07 | 2020-08-13 | Ardelyx, Inc. | Glycyrrhetinic acid derivatives for use in treating hyperkalemia |
WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7534894B2 (en) | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024113A1 (de) * | 1995-12-27 | 1997-07-10 | Hoechst Aktiengesellschaft | VERWENDUNG VON INHIBITOREN DES ZELLULÄREN Na+/H+-EXCHANGERS (NHE) ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR ATEMSTIMULATION |
DE19622222A1 (de) * | 1996-06-03 | 1997-12-04 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide |
EP0937464A2 (de) * | 1997-08-27 | 1999-08-25 | Hoechst Marion Roussel Deutschland GmbH | Pharmazeutisches Kombinationspräparat aus eiem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
WO1999057096A1 (de) * | 1998-04-30 | 1999-11-11 | Merck Patent Gmbh | Biphenylderivate |
-
1999
- 1999-09-22 DE DE19945302A patent/DE19945302A1/de not_active Withdrawn
-
2000
- 2000-09-04 EP EP00965915A patent/EP1214291A1/de not_active Withdrawn
- 2000-09-04 WO PCT/EP2000/008616 patent/WO2001021582A1/de not_active Application Discontinuation
- 2000-09-04 CZ CZ2002815A patent/CZ2002815A3/cs unknown
- 2000-09-04 JP JP2001524962A patent/JP2004500338A/ja active Pending
- 2000-09-04 CN CNA008131600A patent/CN1555356A/zh active Pending
- 2000-09-04 HU HU0202891A patent/HUP0202891A3/hu unknown
- 2000-09-04 BR BR0014199-2A patent/BR0014199A/pt not_active IP Right Cessation
- 2000-09-04 AU AU76497/00A patent/AU7649700A/en not_active Abandoned
- 2000-09-04 SK SK334-2002A patent/SK3342002A3/sk not_active Application Discontinuation
- 2000-09-04 MX MXPA02003087A patent/MXPA02003087A/es unknown
- 2000-09-04 KR KR1020027003735A patent/KR20020033818A/ko not_active Application Discontinuation
- 2000-09-04 CA CA002387529A patent/CA2387529A1/en not_active Abandoned
- 2000-09-04 PL PL00355097A patent/PL355097A1/xx unknown
-
2002
- 2002-03-21 NO NO20021407A patent/NO20021407D0/no unknown
- 2002-04-18 ZA ZA200203095A patent/ZA200203095B/xx unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997024113A1 (de) * | 1995-12-27 | 1997-07-10 | Hoechst Aktiengesellschaft | VERWENDUNG VON INHIBITOREN DES ZELLULÄREN Na+/H+-EXCHANGERS (NHE) ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR ATEMSTIMULATION |
DE19622222A1 (de) * | 1996-06-03 | 1997-12-04 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide |
EP0937464A2 (de) * | 1997-08-27 | 1999-08-25 | Hoechst Marion Roussel Deutschland GmbH | Pharmazeutisches Kombinationspräparat aus eiem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
WO1999057096A1 (de) * | 1998-04-30 | 1999-11-11 | Merck Patent Gmbh | Biphenylderivate |
Non-Patent Citations (1)
Title |
---|
VON DER SAAL, WOLFGANG ET AL: "Syntheses and selective inhibitory activities of terphenyl-bisamidines for serine proteases", ARCH. PHARM. (WEINHEIM, GER.), vol. 329, no. 2, 1996, pages 73 - 82, XP000981547 * |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005516947A (ja) * | 2001-12-21 | 2005-06-09 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 置換されたイミダゾリジン、その製造方法、その医薬又は診断薬としての使用、及び、置換されたイミダゾリジンを含有する医薬 |
US7488746B2 (en) | 2002-06-04 | 2009-02-10 | Sanofi-Aventis Deutschland Gmbh | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
US7317033B2 (en) | 2002-06-04 | 2008-01-08 | Sanofi-Aventis Deutschland Gmbh | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
US7049333B2 (en) | 2002-06-04 | 2006-05-23 | Sanofi-Aventis Deutschland Gmbh | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
US7763643B2 (en) | 2002-06-04 | 2010-07-27 | Sanofi-Aventis Deutschland Gmbh | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
US7442717B2 (en) | 2003-02-04 | 2008-10-28 | Sanofi-Aventis Deutschland Gmbh | Substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid |
US8067614B2 (en) | 2003-02-04 | 2011-11-29 | Sanofi-Aventis Deutschland Gmbh | N-substituted (benzoimidazol-2-yl)phenylamines, processes for their preparation, their use as a medicament or diagnostic aid, and a medicament comprising them |
US7179830B2 (en) | 2003-09-08 | 2007-02-20 | Sanofi-Aventis Deutschland Gmbh | Substituted thienoimidazoles useful for disease treatment and prevention |
US7868003B2 (en) | 2005-01-12 | 2011-01-11 | Sanofi-Aventis | Substituted 4-phenyltetrahydroisoquinolines, pharmaceutical compositions comprising them and therapeutic methods for their use |
WO2009006066A2 (en) | 2007-06-28 | 2009-01-08 | Sanofi-Aventis U.S. Llc | Process for the preparation of benzimidazol thienylamine compounds and intermediates thereof |
WO2010025856A1 (en) | 2008-09-02 | 2010-03-11 | Sanofi-Aventis | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
EP3939964A1 (de) | 2008-12-31 | 2022-01-19 | Ardelyx, Inc. | Kombinationen zur inhibierung des nhe-vermittelten antiports bei der behandlung von mit flüssigkeitsretention und salzüberlastung assoziierten erkrankungen und erkrankungen des magen-darm-trakts |
EP3351248A1 (de) | 2008-12-31 | 2018-07-25 | Ardelyx, Inc. | Verbindungen und verfahren zur inhibierung des nhe-vermittelten antiports bei der behandlung von mit flüssigkeitsretention und salzüberlastung assoziierten erkrankungen und erkrankungen des magen-darm-trakts |
US9556160B2 (en) | 2011-03-15 | 2017-01-31 | Astellas Pharma Inc. | Guanidine compound |
US9051283B2 (en) | 2011-03-15 | 2015-06-09 | Astellas Pharma Inc. | Guanidine compound |
US8716470B2 (en) | 2011-03-15 | 2014-05-06 | Astellas Pharma Inc. | Guanidine compound |
CN103012200B (zh) * | 2011-09-20 | 2014-12-17 | 北京大学 | 具有β-分泌酶抑制功能的化合物及其制备方法与应用 |
CN103012200A (zh) * | 2011-09-20 | 2013-04-03 | 北京大学 | 具有β-分泌酶抑制功能的化合物及其制备方法与应用 |
WO2014029983A1 (en) | 2012-08-21 | 2014-02-27 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US10940146B2 (en) | 2013-04-12 | 2021-03-09 | Ardelyx, Inc. | NHE3-binding compounds and methods for inhibiting phosphate transport |
EP3988120A1 (de) | 2013-04-12 | 2022-04-27 | Ardelyx, Inc. | Nhe3-bindende verbindungen und verfahren zur phosphattransporthemmung |
US10272079B2 (en) | 2013-04-12 | 2019-04-30 | Ardelyx, Inc. | NHE3-binding compounds and methods for inhibiting phosphate transport |
EP3552630A1 (de) | 2013-04-12 | 2019-10-16 | Ardelyx, Inc. | Nhe3-bindende verbindungen zur phosphattransporthemmung |
KR20170034897A (ko) | 2014-07-25 | 2017-03-29 | 다이쇼 세이야꾸 가부시끼가이샤 | 헤테로아릴로 치환된 페닐테트라히드로이소퀴놀린 화합물 |
US9932331B2 (en) | 2014-07-25 | 2018-04-03 | Taisho Pharmaceutical Co., Ltd. | Phenyl tetrahydroisoquinoline compound substituted with heteroaryl |
WO2018129552A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
US11147884B2 (en) | 2017-01-09 | 2021-10-19 | Ardelyx, Inc. | Inhibitors of NHE-mediated antiport |
US11242337B2 (en) | 2017-01-09 | 2022-02-08 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
WO2018129557A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Inhibitors of nhe-mediated antiport |
WO2019060051A1 (en) | 2017-08-04 | 2019-03-28 | Ardelyx, Inc. | GLYCYRRHETINIC ACID DERIVATIVES FOR THE TREATMENT OF HYPERKALIEMIA |
WO2020163642A1 (en) | 2019-02-07 | 2020-08-13 | Ardelyx, Inc. | Glycyrrhetinic acid derivatives for use in treating hyperkalemia |
EP4234016A2 (de) | 2019-02-07 | 2023-08-30 | Ardelyx, Inc. | Glycyrrhetinsäurederivate zur behandlung von hyperkaliämie |
WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Also Published As
Publication number | Publication date |
---|---|
MXPA02003087A (es) | 2003-08-20 |
SK3342002A3 (en) | 2002-07-02 |
AU7649700A (en) | 2001-04-24 |
EP1214291A1 (de) | 2002-06-19 |
NO20021407L (no) | 2002-03-21 |
PL355097A1 (en) | 2004-03-22 |
ZA200203095B (en) | 2003-09-23 |
HUP0202891A3 (en) | 2003-11-28 |
CZ2002815A3 (cs) | 2002-08-14 |
CA2387529A1 (en) | 2001-03-29 |
JP2004500338A (ja) | 2004-01-08 |
KR20020033818A (ko) | 2002-05-07 |
NO20021407D0 (no) | 2002-03-21 |
CN1555356A (zh) | 2004-12-15 |
BR0014199A (pt) | 2002-05-21 |
DE19945302A1 (de) | 2001-03-29 |
HUP0202891A2 (hu) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001021582A1 (de) | Biphenylderivate als nhe-3-inhibitoren | |
EP1794128B1 (de) | Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament | |
US3784582A (en) | 1-amidino-3-(cyanophenyl)ureas | |
EP1458396A1 (de) | 4-aryl-chinazoline und ihre verwendung als nhe-3 inhibitoren | |
DE10019062A1 (de) | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren | |
DE10015248A1 (de) | Bisamidino-Verbindungen als NHE-3 Inhibitoren | |
DE10043667A1 (de) | 2-Guanidino-4-aryl-chinazoline | |
JPS6033823B2 (ja) | サリチルアニリド誘導体及びその製造方法 | |
DE4430212A1 (de) | Ortho-substituierte Benzoesäure-Derivate | |
DE69914614T2 (de) | Ungesättigte hydroximsäurederivate als parp inhibitoren | |
WO2003051866A1 (de) | 2-guanidino-4-heterocyclyl-chinazoline | |
EP0699660B1 (de) | Arylbenzoylguanidine | |
WO1999057096A1 (de) | Biphenylderivate | |
EP1999113B1 (de) | Substituierte 1-amino-4-phenyl-dihydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament | |
DE10224892A1 (de) | Substituierte Thiophene, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament | |
EP1664058B1 (de) | Substituierte thienoimidazole, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltende medikamente | |
DK141749B (da) | Analogifremgangsmåde til fremstilling af pyridincarboxamidoethylbenzensulfonylurinstof-forbindelser. | |
EP1999112B1 (de) | Substituierte 2-amino-4-phenyl-dihydrochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament | |
DE10102053A1 (de) | Piperazinylcarbonylchinoline und -isochinoline | |
DE19607096A1 (de) | Endothelin-Rezeptor-Antagonisten | |
DE4422517A1 (de) | Neue (2-(3,4-Dimethoxy-phenyl)-ethyl)-(2-phenoxy-ethyl)-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
AT367740B (de) | Verfahren zur herstellung von neuen omega-(2(n-niederalkyl-benzamido)-phenyl)-alkansaeuren und ihren salzen | |
AT367031B (de) | Verfahren zur herstellung von neuen omega-(2-(nniederalkyl-benzamido)-phenyl)-alkans[uren und ihren salzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000965915 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2002-815 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3342002 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2387529 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008131600 Country of ref document: CN Ref document number: 1020027003735 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2001 524962 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/003087 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 76497/00 Country of ref document: AU Ref document number: IN/PCT/2002/492/KOL Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2002 2002109470 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200200360 Country of ref document: VN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027003735 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2000965915 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10088684 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-815 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000965915 Country of ref document: EP |